Title
Category
Credits
Event date
Cost
  • Substance Use Disorders in Alabama (SUDA)
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
National and Alabama use patterns & trends will be discussed including data from treatment admissions. Risk factors and DSM criteria along with prevalence and epidemiology will be reviewed. A description of available products and relative potency. We will review heavily utilized alternatives like delta-8 and/or delta-10 along with their legal status. We will review in detail the new AL Medical Cannabis Use from the Alabama Compassion Act in 2021 that will be implemented starting 9/1/22. 
  • Substance Use Disorders in Alabama (SUDA)
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This presentation will review National and AL data on OUD and use pattern trends. We will discuss risk factors, behavioral clues, and DSM criteria. Epidemiology and prevalence will be discussed. The changing opioid crisis will be discussed with increased emphasis on illicit synthetic opioid use rather than the prescription opioid use driving the current crisis. We will discuss impact of medical cannabis use on patients prescribed opioids for various conditions. 
  • Opioid Training Institute
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
$0.00
This is a case-based presentation on the practical application of risk mitigation strategies already discussed in Part I. Team-based care and clinic optimization will be discussed followed by the presentation of 3 clinical cases that address multiple issues common to practice and clinical pearls will be shared to reinforce previous learning and assist with clinical implementation.
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding the importance of taking a multidisciplinary, patient centered approach to substance use disorder treatment.
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding the history, current state, and impact of substance use in the U.S. particularly focusing on opioid use and related polydrug use.
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding harm reduction techniques around opioid use and related polydrug use.
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding stigma issues and appropriate language around substance use disorder.
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding how to communicate with patients that have substance use disorder.
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding when and how to taper benzodiazepines.
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding antidotes for responding to an overdose.

Pages